All In Biotech

Drug Trial Radar · NCT06470191

A Clinical Study of B007 in the Treatment of Primary Membranous Nephropathy.

A Multicenter, Randomized, Controlled, Open Phase II/III Clinical Study to Evaluate the Efficacy and Safety of B007 Versus Cyclosporine in the Treatment of Primary Membranous Nephropathy.

Last checked: Nov 19, 2026Latest source record: May 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 216 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

216

Planned (sponsor's estimate)

Start

Jul 30, 2024

Primary completion

Dec 31, 2026

Study completion Dec 31, 2026

Sponsor

Sponsor type
Industry
Collaborators
Shanghai Pharmaceuticals Holding Co., Ltd
First posted
Jun 24, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2 / Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To evaluate the efficacy and safety of B007 in the Treatment of Primary Membranous Nephropathy

Conditions

  • Primary Membranous Nephropathy

Interventions

  • B007Drug

    B007: Subcutaneous injection was administered on days 1 and 15

  • Cyclosporin CapsulesDrug

    Cyclosporin Capsules: Orally, 3.5 mg/kg/d;

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. ORR(Overall Remission Rate)Time frame: Approximately 2 years

Locations

21 sites in 1 country. Site status is shown where the registry gives one.

  • Beijing Tsinghua Changgung Hospital

    Beijing, China · Recruiting

  • Peking university first hospital

    Beijing, China · Recruiting

  • The Second Norman Bethune Hospital of Jilin University

    Changchun, China · Recruiting

  • The First Affiliated Hospital, Sun Yat-sen University

    Guangzhou, China · Recruiting

  • Zhujiang Hospital of Southern Medical University

    Guangzhou, China · Recruiting

  • Sir Run Run Shaw Hospital , affiliated with the Zhejiang University School of Medicine

    Hangzhou, China · Recruiting

  • The First Affiliated Hospital, Zhejiang University School of Medicine

    Hangzhou, China · Recruiting

  • Shandong Provincial Hospital

    Jinan, China · Recruiting

  • The First Affiliated Hospital of Guangxi Medical University

    Nanning, China · Recruiting

  • Affiliated Hospital of Nantong University

    Nantong, China · Recruiting

  • The Affiliated Hospital of Qingdao University

    Qingdao, China · Recruiting

  • Northern Theater Command General Hospital

    Shenyang, China · Recruiting

  • Shengjing Hospital affiliated to China Medical University

    Shenyang, China · Recruiting

  • Peking University Shenzhen Hospital

    Shenzhen, China · Recruiting

  • Renmin Hospital of Wuhan University

    Wuhan, China · Recruiting

  • Wuxi People's Hospital

    Wuxi, China · Recruiting

  • Xi'an Daxing Hospital

    Xi'an, China · Recruiting

  • The Second Affiliated Hospital of Xingtai Medical college

    Xingtai, China · Recruiting

  • Northern Jiangsu People's Hospital

    Yangzhou, China · Recruiting

  • Yantai Yuhuangding Hospital

    Yantai, China · Recruiting

  • The First People's Hospital of Zigong

    Zigong, China · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.